Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance

Melanoma is a highly malignant skin cancer with high propensity to metastasize and develop drug resistance, making it a difficult cancer to treat. Current therapies targeting BRAF (V600) mutations are initially effective, but eventually tumors overcome drug sensitivity and reoccur. This process is a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Reger de Moura, Coralie, Prunotto, Marco, Sohail, Anjum, Battistella, Maxime, Jouenne, Fanelie, Marbach, Daniel, Lebbé, Celeste, Fridman, Rafael, Mourah, Samia
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7516126/
https://ncbi.nlm.nih.gov/pubmed/33014862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01748
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados